QT
PETX

Quantbot Technologies’s Aratana Therapeutics, Inc. PETX Stock Holding History

Quantbot Technologies’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,301
Closed -$40K – 1481
2016
Q3 		$40K Buy
+4,301
New +$35.7K ﹤0.01% 885
2016
Q2 		– Sell
-1,054
Closed -$5K – 1495
2016
Q1 		$5K Sell
1,054
-446
-30% -$1.68K ﹤0.01% 1084
2015
Q4 		$8K Sell
1,500
-1,169
-44% -$7.73K ﹤0.01% 997
2015
Q3 		$22K Buy
+2,669
New +$45.2K ﹤0.01% 1016

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Quantbot Technologies's PETX Position: Q4 2016 in Review

Quantbot Technologies sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2016, closing a stake of 4,301 shares — an estimated $40K sold.

Quantbot Technologies first reported a position in PETX in Q3 2015 and held it in 4 quarters. The position peaked at $40K in Q3 2016. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

  • Quantbot Technologies reported no remaining Aratana Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Quantbot Technologies sold 4,301 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $40K.
  • Quantbot Technologies first reported a position in Aratana Therapeutics, Inc. in Q3 2015 and held it in 4 quarters.
  • Quantbot Technologies's Aratana Therapeutics, Inc. position peaked at $40K in Q3 2016.
  • 107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on Quantbot Technologies's 13F filing for Q4 2016, filed 9 Feb 2017.